HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1
1.0.0 - STU1
HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1
1.0.0 - STU1
This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v1.0.0: STU 1) based on FHIR R4. The current version which supercedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions 
Summary
| Defining URL: | http://hl7.org/fhir/us/mcode/ValueSet/mcode-tumor-marker-test-vs |
| Version: | 1.0.0 |
| Name: | TumorMarkerTestVS |
| Status: | Active |
| Definition: | Codes representing tests for tumor markers. This value set of LOINC codes is not comprehensive and can be extended. LOINC codes are preferred. Other vocabularies can be used only if the test of interest is not covered by LOINC. FHIR implementation note: At the current time, profiles for the specific LOINC tests mentioned here do not exist. |
| Publisher: | HL7 International Clinical Interoperability Council |
| Source Resource: | XML / JSON / Turtle |
References
http://loinc.org| Code | Display | |
| 1695-6 | 5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine | |
| 31203-3 | 5-Hydroxyindoleacetate [Mass/volume] in 24 hour Urine | |
| 1692-3 | 5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid | |
| 1693-1 | 5-Hydroxyindoleacetate [Mass/volume] in Serum or Plasma | |
| 1694-9 | 5-Hydroxyindoleacetate [Mass/volume] in Urine | |
| 72820-4 | 5-Hydroxyindoleacetate [Mass/volume] in Urine by Confirmatory method | |
| 14573-0 | 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine | |
| 25971-3 | 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine | |
| 47544-2 | 5-Hydroxyindoleacetate [Moles/volume] in Cerebral spinal fluid | |
| 74769-1 | 5-Hydroxyindoleacetate [Moles/volume] in Platelet rich plasma | |
| 50149-4 | 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma | |
| 15009-4 | 5-Hydroxyindoleacetate [Moles/volume] in Urine | |
| 12172-3 | 5-Hydroxyindoleacetate [Presence] in 24 hour Urine | |
| 48168-9 | 5-Hydroxyindoleacetate [Presence] in Urine | |
| 11145-0 | 5-Hydroxyindoleacetate/​Creatinine [Mass Ratio] in Urine | |
| 44909-0 | 5-Hydroxyindoleacetate and Creatinine [Interpretation] in Urine | |
| 10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain | |
| 11207-8 | Alpha-1-Fetoprotein [Mass/volume] in Body fluid | |
| 1833-3 | Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid | |
| 54348-8 | Alpha-1-Fetoprotein [Mass/volume] in Cord blood | |
| 49761-0 | Alpha-1-Fetoprotein [Mass/volume] in Peritoneal fluid | |
| 49762-8 | Alpha-1-Fetoprotein [Mass/volume] in Pleural fluid | |
| 1834-1 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma | |
| 83073-7 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay | |
| 19173-4 | Alpha-1-Fetoprotein [Moles/volume] in Pleural fluid | |
| 19177-5 | Alpha-1-Fetoprotein [Moles/volume] in Serum or Plasma | |
| 31993-9 | Alpha-1-Fetoprotein [Presence] in Serum or Plasma | |
| 44910-8 | Alpha-1-Fetoprotein [Units/volume] in Body fluid | |
| 59564-5 | Alpha-1-Fetoprotein [Units/volume] in Cerebral spinal fluid | |
| 19172-6 | Alpha-1-Fetoprotein [Units/volume] in Pleural fluid | |
| 19176-7 | Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma | |
| 83072-9 | Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma by Immunoassay | |
| 41274-2 | Alpha-1-Fetoprotein interpretation in Serum or Plasma | |
| 49246-2 | Alpha-1-Fetoprotein interpretation in Serum or Plasma Narrative | |
| 49585-3 | Alpha-1-Fetoprotein multiple of the median cutoff [Multiple of the median] in Serum or Plasma | |
| 53962-7 | Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma | |
| 53960-1 | Alpha-1-fetoprotein.tumor marker [Moles/volume] in Serum or Plasma | |
| 53961-9 | Alpha-1-fetoprotein.tumor marker [Units/volume] in Serum or Plasma | |
| 10873-8 | Beta-2-Microglobulin [Mass/time] in 24 hour Urine | |
| 54356-1 | Beta-2-Microglobulin [Mass/volume] in 24 hour Urine | |
| 48166-3 | Beta-2-Microglobulin [Mass/volume] in Body fluid | |
| 1951-3 | Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid | |
| 49081-3 | Beta-2-Microglobulin [Mass/volume] in Dialysis fluid | |
| 88711-7 | Beta-2-Microglobulin [Mass/volume] in Peritoneal dialysis fluid | |
| 59217-0 | Beta-2-Microglobulin [Mass/volume] in Peritoneal fluid | |
| 59218-8 | Beta-2-Microglobulin [Mass/volume] in Pleural fluid | |
| 1952-1 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma | |
| 87708-4 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma --post dialysis | |
| 83078-6 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay | |
| 1953-9 | Beta-2-Microglobulin [Mass/volume] in Urine | |
| 83077-8 | Beta-2-Microglobulin [Mass/volume] in Urine by Immunoassay | |
| 56662-0 | Beta-2-Microglobulin [Moles/time] in 24 hour Urine | |
| 50824-2 | Beta-2-Microglobulin [Moles/volume] in 24 hour Urine | |
| 39458-5 | Beta-2-Microglobulin [Moles/volume] in Body fluid | |
| 32301-4 | Beta-2-Microglobulin [Moles/volume] in Cerebral spinal fluid | |
| 14626-6 | Beta-2-Microglobulin [Moles/volume] in Serum | |
| 76484-5 | Beta-2-Microglobulin [Moles/volume] in Serum or Plasma | |
| 32302-2 | Beta-2-Microglobulin [Moles/volume] in Urine | |
| 43919-0 | Beta-2-Microglobulin [Presence] in Cerebral spinal fluid | |
| 43818-4 | Beta-2-Microglobulin [Presence] in Serum | |
| 43819-2 | Beta-2-Microglobulin [Presence] in Urine | |
| 83076-0 | Beta-2-Microglobulin [Units/volume] in Serum or Plasma by Immunoassay | |
| 83079-4 | Beta-2-Microglobulin [Units/volume] in Urine by Immunoassay | |
| 10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain | |
| 54355-3 | Beta-2-Microglobulin in CSF/Beta-2-Microglobulin in serum | |
| 56786-7 | Beta-2-Microglobulin.tumor marker [Mass/volume] in Serum | |
| 2006-5 | Cancer Ag 125 [Presence] in Serum or Plasma | |
| 48677-9 | Cancer Ag 125 [Presence] in Tissue by Immune stain | |
| 11210-2 | Cancer Ag 125 [Units/volume] in Body fluid | |
| 15156-3 | Cancer Ag 125 [Units/volume] in Body fluid by Dilution | |
| 50775-6 | Cancer Ag 125 [Units/volume] in Cerebral spinal fluid | |
| 68923-2 | Cancer Ag 125 [Units/volume] in Pericardial fluid | |
| 59040-6 | Cancer Ag 125 [Units/volume] in Peritoneal dialysis fluid | |
| 40618-1 | Cancer Ag 125 [Units/volume] in Peritoneal fluid | |
| 19165-0 | Cancer Ag 125 [Units/volume] in Pleural fluid | |
| 10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma | |
| 15157-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma by Dilution | |
| 83082-8 | Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay | |
| 2007-3 | Cancer Ag 15-3 [Presence] in Serum or Plasma | |
| 29153-4 | Cancer Ag 15-3 [Units/volume] in Body fluid | |
| 50776-4 | Cancer Ag 15-3 [Units/volume] in Cerebral spinal fluid | |
| 50777-2 | Cancer Ag 15-3 [Units/volume] in Pericardial fluid | |
| 50778-0 | Cancer Ag 15-3 [Units/volume] in Peritoneal fluid | |
| 19186-6 | Cancer Ag 15-3 [Units/volume] in Pleural fluid | |
| 6875-9 | Cancer Ag 15-3 [Units/volume] in Serum or Plasma | |
| 83083-6 | Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay | |
| 2009-9 | Cancer Ag 19-9 [Presence] in Serum or Plasma | |
| 26924-1 | Cancer Ag 19-9 [Units/volume] in Body fluid | |
| 50779-8 | Cancer Ag 19-9 [Units/volume] in Cerebral spinal fluid | |
| 50780-6 | Cancer Ag 19-9 [Units/volume] in Pericardial fluid | |
| 50781-4 | Cancer Ag 19-9 [Units/volume] in Peritoneal fluid | |
| 19163-5 | Cancer Ag 19-9 [Units/volume] in Pleural fluid | |
| 24108-3 | Cancer Ag 19-9 [Units/volume] in Serum or Plasma | |
| 83084-4 | Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay | |
| 2012-3 | Cancer Ag 27-29 [Presence] in Serum or Plasma | |
| 50782-2 | Cancer Ag 27-29 [Units/volume] in Cerebral spinal fluid | |
| 19187-4 | Cancer Ag 27-29 [Units/volume] in Pleural fluid | |
| 17842-6 | Cancer Ag 27-29 [Units/volume] in Serum or Plasma | |
| 12515-3 | Carcinoembryonic Ag [Mass/volume] in Body fluid | |
| 2037-0 | Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid | |
| 40621-5 | Carcinoembryonic Ag [Mass/volume] in Pericardial fluid | |
| 40622-3 | Carcinoembryonic Ag [Mass/volume] in Peritoneal fluid | |
| 19169-2 | Carcinoembryonic Ag [Mass/volume] in Pleural fluid | |
| 2038-8 | Carcinoembryonic Ag [Mass/volume] in Semen | |
| 2039-6 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma | |
| 83085-1 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay | |
| 19170-0 | Carcinoembryonic Ag [Moles/volume] in Pleural fluid | |
| 19167-6 | Carcinoembryonic Ag [Moles/volume] in Serum or Plasma | |
| 10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain | |
| 19168-4 | Carcinoembryonic Ag [Units/volume] in Pleural fluid | |
| 10560-1 | Carcinoembryonic Ag [Units/volume] in Semen | |
| 19166-8 | Carcinoembryonic Ag [Units/volume] in Serum or Plasma | |
| 85337-4 | Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain | |
| 40556-3 | Estrogen receptor Ag [Presence] in Tissue by Immune stain | |
| 16112-5 | Estrogen receptor [Interpretation] in Tissue | |
| 14130-9 | Estrogen receptor [Moles/mass] in Tissue | |
| 85310-1 | Estrogen receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain | |
| 10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain | |
| 48676-1 | HER2 [Interpretation] in Tissue | |
| 32996-1 | HER2 [Mass/volume] in Serum | |
| 42914-2 | HER2 [Mass/volume] in Serum by Immunoassay | |
| 85318-4 | HER2 [Presence] in Breast cancer specimen by FISH | |
| 85319-2 | HER2 [Presence] in Breast cancer specimen by Immune stain | |
| 51981-9 | HER2 [Presence] in Serum by Immunoassay | |
| 31150-6 | HER2 [Presence] in Tissue by FISH | |
| 72383-3 | HER2 [Presence] in Tissue by Immunoassay | |
| 72382-5 | HER2 [Units/volume] in Tissue by Immunoassay | |
| 18474-7 | HER2 Ag [Presence] in Tissue by Immune stain | |
| 49683-6 | HER2 gene copy number/Chromosome 17 copy number in Tissue by FISH | |
| 74860-8 | HER2 gene copy number/nucleus in Tissue by FISH | |
| 74885-5 | HER2 panel - Tissue by FISH | |
| 83054-7 | PD-L1 by clone 22C3 [Interpretation] in Tissue by Immune stain Narrative | |
| 83052-1 | PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain | |
| 83056-2 | PD-L1 by clone 28-8 [Interpretation] in Tissue by Immune stain Narrative | |
| 83055-4 | PD-L1 by clone 28-8 [Presence] in Tissue by Immune stain | |
| 83057-0 | PD-L1 by clone SP142 [Presence] in Tissue by Immune stain | |
| 83053-9 | Cells.programmed cell death ligand 1/100 viable tumor cells in Tissue by Immune stain. (source: LOINC) | |
| 85339-0 | Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain | |
| 40557-1 | Progesterone receptor Ag [Presence] in Tissue by Immune stain | |
| 16113-3 | Progesterone receptor [Interpretation] in Tissue | |
| 10861-3 | Progesterone receptor [Mass/mass] in Tissue | |
| 31207-4 | Progesterone receptor [Moles/mass] in Tissue | |
| 85331-7 | Progesterone receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain | |
| 47738-0 | Prostate specific Ag [Mass/volume] in Body fluid | |
| 59230-3 | Prostate specific Ag [Mass/volume] in Cerebral spinal fluid | |
| 59223-8 | Prostate specific Ag [Mass/volume] in Peritoneal fluid | |
| 59221-2 | Prostate specific Ag [Mass/volume] in Pleural fluid | |
| 19199-9 | Prostate specific Ag [Mass/volume] in Semen | |
| 2857-1 | Prostate specific Ag [Mass/volume] in Serum or Plasma | |
| 35741-8 | Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL | |
| 83112-3 | Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay | |
| 34611-4 | Prostate specific Ag [Mass/volume] in Urine | |
| 19200-5 | Prostate specific Ag [Moles/volume] in Semen | |
| 19197-3 | Prostate specific Ag [Moles/volume] in Serum or Plasma | |
| 10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain | |
| 19198-1 | Prostate specific Ag [Units/volume] in Semen | |
| 19195-7 | Prostate specific Ag [Units/volume] in Serum or Plasma | |
| 15325-4 | Prostate specific Ag/Prostate volume calculated | |
| 15323-9 | Prostate specific Ag/Prostate volume calculated from height, width and length | |
| 15324-7 | Prostate specific Ag/Prostate volume calculated from planimetry |
This value set contains 160 concepts
Expansion based on LOINC version 2.66
All codes from system http://loinc.org
| Code | Display |
| 1695-6 | 5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine |
| 31203-3 | 5-Hydroxyindoleacetate [Mass/volume] in 24 hour Urine |
| 1692-3 | 5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid |
| 1693-1 | 5-Hydroxyindoleacetate [Mass/volume] in Serum or Plasma |
| 1694-9 | 5-Hydroxyindoleacetate [Mass/volume] in Urine |
| 72820-4 | 5-Hydroxyindoleacetate [Mass/volume] in Urine by Confirmatory method |
| 14573-0 | 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine |
| 25971-3 | 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine |
| 47544-2 | 5-Hydroxyindoleacetate [Moles/volume] in Cerebral spinal fluid |
| 74769-1 | 5-Hydroxyindoleacetate [Moles/volume] in Platelet rich plasma |
| 50149-4 | 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma |
| 15009-4 | 5-Hydroxyindoleacetate [Moles/volume] in Urine |
| 12172-3 | 5-Hydroxyindoleacetate [Presence] in 24 hour Urine |
| 48168-9 | 5-Hydroxyindoleacetate [Presence] in Urine |
| 11145-0 | 5-Hydroxyindoleacetate/​Creatinine [Mass Ratio] in Urine |
| 44909-0 | 5-Hydroxyindoleacetate and Creatinine [Interpretation] in Urine |
| 10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
| 11207-8 | Alpha-1-Fetoprotein [Mass/volume] in Body fluid |
| 1833-3 | Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid |
| 54348-8 | Alpha-1-Fetoprotein [Mass/volume] in Cord blood |
| 49761-0 | Alpha-1-Fetoprotein [Mass/volume] in Peritoneal fluid |
| 49762-8 | Alpha-1-Fetoprotein [Mass/volume] in Pleural fluid |
| 1834-1 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma |
| 83073-7 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay |
| 19173-4 | Alpha-1-Fetoprotein [Moles/volume] in Pleural fluid |
| 19177-5 | Alpha-1-Fetoprotein [Moles/volume] in Serum or Plasma |
| 31993-9 | Alpha-1-Fetoprotein [Presence] in Serum or Plasma |
| 44910-8 | Alpha-1-Fetoprotein [Units/volume] in Body fluid |
| 59564-5 | Alpha-1-Fetoprotein [Units/volume] in Cerebral spinal fluid |
| 19172-6 | Alpha-1-Fetoprotein [Units/volume] in Pleural fluid |
| 19176-7 | Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma |
| 83072-9 | Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma by Immunoassay |
| 41274-2 | Alpha-1-Fetoprotein interpretation in Serum or Plasma |
| 49246-2 | Alpha-1-Fetoprotein interpretation in Serum or Plasma Narrative |
| 49585-3 | Alpha-1-Fetoprotein multiple of the median cutoff [Multiple of the median] in Serum or Plasma |
| 53962-7 | Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma |
| 53960-1 | Alpha-1-fetoprotein.tumor marker [Moles/volume] in Serum or Plasma |
| 53961-9 | Alpha-1-fetoprotein.tumor marker [Units/volume] in Serum or Plasma |
| 10873-8 | Beta-2-Microglobulin [Mass/time] in 24 hour Urine |
| 54356-1 | Beta-2-Microglobulin [Mass/volume] in 24 hour Urine |
| 48166-3 | Beta-2-Microglobulin [Mass/volume] in Body fluid |
| 1951-3 | Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid |
| 49081-3 | Beta-2-Microglobulin [Mass/volume] in Dialysis fluid |
| 88711-7 | Beta-2-Microglobulin [Mass/volume] in Peritoneal dialysis fluid |
| 59217-0 | Beta-2-Microglobulin [Mass/volume] in Peritoneal fluid |
| 59218-8 | Beta-2-Microglobulin [Mass/volume] in Pleural fluid |
| 1952-1 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma |
| 87708-4 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma --post dialysis |
| 83078-6 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay |
| 1953-9 | Beta-2-Microglobulin [Mass/volume] in Urine |
| 83077-8 | Beta-2-Microglobulin [Mass/volume] in Urine by Immunoassay |
| 56662-0 | Beta-2-Microglobulin [Moles/time] in 24 hour Urine |
| 50824-2 | Beta-2-Microglobulin [Moles/volume] in 24 hour Urine |
| 39458-5 | Beta-2-Microglobulin [Moles/volume] in Body fluid |
| 32301-4 | Beta-2-Microglobulin [Moles/volume] in Cerebral spinal fluid |
| 14626-6 | Beta-2-Microglobulin [Moles/volume] in Serum |
| 76484-5 | Beta-2-Microglobulin [Moles/volume] in Serum or Plasma |
| 32302-2 | Beta-2-Microglobulin [Moles/volume] in Urine |
| 43919-0 | Beta-2-Microglobulin [Presence] in Cerebral spinal fluid |
| 43818-4 | Beta-2-Microglobulin [Presence] in Serum |
| 43819-2 | Beta-2-Microglobulin [Presence] in Urine |
| 83076-0 | Beta-2-Microglobulin [Units/volume] in Serum or Plasma by Immunoassay |
| 83079-4 | Beta-2-Microglobulin [Units/volume] in Urine by Immunoassay |
| 10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain |
| 54355-3 | Beta-2-Microglobulin in CSF/Beta-2-Microglobulin in serum |
| 56786-7 | Beta-2-Microglobulin.tumor marker [Mass/volume] in Serum |
| 2006-5 | Cancer Ag 125 [Presence] in Serum or Plasma |
| 48677-9 | Cancer Ag 125 [Presence] in Tissue by Immune stain |
| 11210-2 | Cancer Ag 125 [Units/volume] in Body fluid |
| 15156-3 | Cancer Ag 125 [Units/volume] in Body fluid by Dilution |
| 50775-6 | Cancer Ag 125 [Units/volume] in Cerebral spinal fluid |
| 68923-2 | Cancer Ag 125 [Units/volume] in Pericardial fluid |
| 59040-6 | Cancer Ag 125 [Units/volume] in Peritoneal dialysis fluid |
| 40618-1 | Cancer Ag 125 [Units/volume] in Peritoneal fluid |
| 19165-0 | Cancer Ag 125 [Units/volume] in Pleural fluid |
| 10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma |
| 15157-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma by Dilution |
| 83082-8 | Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay |
| 2007-3 | Cancer Ag 15-3 [Presence] in Serum or Plasma |
| 29153-4 | Cancer Ag 15-3 [Units/volume] in Body fluid |
| 50776-4 | Cancer Ag 15-3 [Units/volume] in Cerebral spinal fluid |
| 50777-2 | Cancer Ag 15-3 [Units/volume] in Pericardial fluid |
| 50778-0 | Cancer Ag 15-3 [Units/volume] in Peritoneal fluid |
| 19186-6 | Cancer Ag 15-3 [Units/volume] in Pleural fluid |
| 6875-9 | Cancer Ag 15-3 [Units/volume] in Serum or Plasma |
| 83083-6 | Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay |
| 2009-9 | Cancer Ag 19-9 [Presence] in Serum or Plasma |
| 26924-1 | Cancer Ag 19-9 [Units/volume] in Body fluid |
| 50779-8 | Cancer Ag 19-9 [Units/volume] in Cerebral spinal fluid |
| 50780-6 | Cancer Ag 19-9 [Units/volume] in Pericardial fluid |
| 50781-4 | Cancer Ag 19-9 [Units/volume] in Peritoneal fluid |
| 19163-5 | Cancer Ag 19-9 [Units/volume] in Pleural fluid |
| 24108-3 | Cancer Ag 19-9 [Units/volume] in Serum or Plasma |
| 83084-4 | Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay |
| 2012-3 | Cancer Ag 27-29 [Presence] in Serum or Plasma |
| 50782-2 | Cancer Ag 27-29 [Units/volume] in Cerebral spinal fluid |
| 19187-4 | Cancer Ag 27-29 [Units/volume] in Pleural fluid |
| 17842-6 | Cancer Ag 27-29 [Units/volume] in Serum or Plasma |
| 12515-3 | Carcinoembryonic Ag [Mass/volume] in Body fluid |
| 2037-0 | Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid |
| 40621-5 | Carcinoembryonic Ag [Mass/volume] in Pericardial fluid |
| 40622-3 | Carcinoembryonic Ag [Mass/volume] in Peritoneal fluid |
| 19169-2 | Carcinoembryonic Ag [Mass/volume] in Pleural fluid |
| 2038-8 | Carcinoembryonic Ag [Mass/volume] in Semen |
| 2039-6 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma |
| 83085-1 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay |
| 19170-0 | Carcinoembryonic Ag [Moles/volume] in Pleural fluid |
| 19167-6 | Carcinoembryonic Ag [Moles/volume] in Serum or Plasma |
| 10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain |
| 19168-4 | Carcinoembryonic Ag [Units/volume] in Pleural fluid |
| 10560-1 | Carcinoembryonic Ag [Units/volume] in Semen |
| 19166-8 | Carcinoembryonic Ag [Units/volume] in Serum or Plasma |
| 85337-4 | Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain |
| 40556-3 | Estrogen receptor Ag [Presence] in Tissue by Immune stain |
| 16112-5 | Estrogen receptor [Interpretation] in Tissue |
| 14130-9 | Estrogen receptor [Moles/mass] in Tissue |
| 85310-1 | Estrogen receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain |
| 10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain |
| 48676-1 | HER2 [Interpretation] in Tissue |
| 32996-1 | HER2 [Mass/volume] in Serum |
| 42914-2 | HER2 [Mass/volume] in Serum by Immunoassay |
| 85318-4 | HER2 [Presence] in Breast cancer specimen by FISH |
| 85319-2 | HER2 [Presence] in Breast cancer specimen by Immune stain |
| 51981-9 | HER2 [Presence] in Serum by Immunoassay |
| 31150-6 | HER2 [Presence] in Tissue by FISH |
| 72383-3 | HER2 [Presence] in Tissue by Immunoassay |
| 72382-5 | HER2 [Units/volume] in Tissue by Immunoassay |
| 18474-7 | HER2 Ag [Presence] in Tissue by Immune stain |
| 49683-6 | HER2 gene copy number/Chromosome 17 copy number in Tissue by FISH |
| 74860-8 | HER2 gene copy number/nucleus in Tissue by FISH |
| 74885-5 | HER2 panel - Tissue by FISH |
| 83054-7 | PD-L1 by clone 22C3 [Interpretation] in Tissue by Immune stain Narrative |
| 83052-1 | PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain |
| 83056-2 | PD-L1 by clone 28-8 [Interpretation] in Tissue by Immune stain Narrative |
| 83055-4 | PD-L1 by clone 28-8 [Presence] in Tissue by Immune stain |
| 83057-0 | PD-L1 by clone SP142 [Presence] in Tissue by Immune stain |
| 83053-9 | Cells.programmed cell death ligand 1/100 viable tumor cells in Tissue by Immune stain. (source: LOINC) |
| 85339-0 | Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain |
| 40557-1 | Progesterone receptor Ag [Presence] in Tissue by Immune stain |
| 16113-3 | Progesterone receptor [Interpretation] in Tissue |
| 10861-3 | Progesterone receptor [Mass/mass] in Tissue |
| 31207-4 | Progesterone receptor [Moles/mass] in Tissue |
| 85331-7 | Progesterone receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain |
| 47738-0 | Prostate specific Ag [Mass/volume] in Body fluid |
| 59230-3 | Prostate specific Ag [Mass/volume] in Cerebral spinal fluid |
| 59223-8 | Prostate specific Ag [Mass/volume] in Peritoneal fluid |
| 59221-2 | Prostate specific Ag [Mass/volume] in Pleural fluid |
| 19199-9 | Prostate specific Ag [Mass/volume] in Semen |
| 2857-1 | Prostate specific Ag [Mass/volume] in Serum or Plasma |
| 35741-8 | Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL |
| 83112-3 | Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay |
| 34611-4 | Prostate specific Ag [Mass/volume] in Urine |
| 19200-5 | Prostate specific Ag [Moles/volume] in Semen |
| 19197-3 | Prostate specific Ag [Moles/volume] in Serum or Plasma |
| 10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain |
| 19198-1 | Prostate specific Ag [Units/volume] in Semen |
| 19195-7 | Prostate specific Ag [Units/volume] in Serum or Plasma |
| 15325-4 | Prostate specific Ag/Prostate volume calculated |
| 15323-9 | Prostate specific Ag/Prostate volume calculated from height, width and length |
| 15324-7 | Prostate specific Ag/Prostate volume calculated from planimetry |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
IG © 2019+ HL7 International Clinical Interoperability Council. Package hl7.fhir.us.mcode#1.0.0 based on FHIR 4.0.1. Generated 2020-03-18
Links: Table of Contents |
QA Report | Search
| Version History |
|
Propose a change